Alto Neuroscience, Inc. SEC filings ANRO
Alto Neuroscience, Inc. has 196 filings in SEC EDGAR's recent list, going back to Nov 22, 2023. Its latest annual report, Form ARS, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 27, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 30, 2026 | — |
| 4 | Insider transaction | Oct 5, 2026 | Oct 2, 2026 |
| 4 | Insider transaction | Oct 1, 2026 | Sep 29, 2026 |
| 144 | Notice of proposed sale | Sep 29, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 27, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 20, 2026 | — |
| 4 | Insider transaction | May 29, 2026 | May 27, 2026 |
| 3 | Initial insider ownership | May 29, 2026 | May 27, 2026 |
| 4 | Insider transaction | May 15, 2026 | May 14, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| 4 | Insider transaction | May 14, 2026 | May 12, 2026 |
| 4 | Insider transaction | May 14, 2026 | May 12, 2026 |
| 4 | Insider transaction | May 14, 2026 | May 12, 2026 |
| 4 | Insider transaction | May 14, 2026 | May 12, 2026 |
| 4 | Insider transaction | May 14, 2026 | May 12, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 1, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 18, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| 4 | Insider transaction | Feb 13, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 27, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 10, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 4 | Insider transaction | Aug 14, 2025 | Aug 12, 2025 |
| 3 | Initial insider ownership | Aug 14, 2025 | Aug 12, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 16, 2025 | — |
| 4 | Insider transaction | Jul 8, 2025 | Jul 3, 2025 |
| 4 | Insider transaction | Jul 8, 2025 | Jul 3, 2025 |
| 4 | Insider transaction | Jul 8, 2025 | Jul 3, 2025 |
| 4 | Insider transaction | Jul 8, 2025 | Jul 3, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| 4 | Insider transaction | May 15, 2025 | May 13, 2025 |
| 4 | Insider transaction | May 15, 2025 | May 13, 2025 |
| 4 | Insider transaction | May 15, 2025 | May 13, 2025 |
| 4 | Insider transaction | May 15, 2025 | May 13, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2025 | — |
| 4 | Insider transaction | Feb 7, 2025 | Feb 5, 2025 |
| 4 | Insider transaction | Feb 7, 2025 | Feb 5, 2025 |
| 4 | Insider transaction | Feb 7, 2025 | Feb 5, 2025 |
| 4 | Insider transaction | Feb 7, 2025 | Feb 5, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 12, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 8, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Oct 21, 2024 | — |
| 4 | Insider transaction | Jul 11, 2024 | Jul 9, 2024 |
| 4 | Insider transaction | May 22, 2024 | May 20, 2024 |
| 3 | Initial insider ownership | May 22, 2024 | May 20, 2024 |
| 4 | Insider transaction | Apr 1, 2024 | Mar 28, 2024 |
| SC 13G | Ownership over 5% (passive) | Mar 29, 2024 | — |
| 4 | Insider transaction | Mar 12, 2024 | Mar 8, 2024 |
| 3 | Initial insider ownership | Mar 12, 2024 | Mar 8, 2024 |
| 4 | Insider transaction | Mar 6, 2024 | Feb 6, 2024 |
| 4 | Insider transaction | Mar 5, 2024 | Mar 1, 2024 |
| 4 | Insider transaction | Mar 5, 2024 | Mar 1, 2024 |
| 4 | Insider transaction | Mar 5, 2024 | Mar 1, 2024 |
| SC 13G | Ownership over 5% (passive) | Feb 9, 2024 | — |
| 4 | Insider transaction | Feb 8, 2024 | Feb 6, 2024 |
| 4 | Insider transaction | Feb 7, 2024 | Feb 6, 2024 |
| 4 | Insider transaction | Feb 7, 2024 | Feb 6, 2024 |
| 4 | Insider transaction | Feb 7, 2024 | Feb 6, 2024 |
| 4 | Insider transaction | Feb 7, 2024 | Feb 6, 2024 |
| 4 | Insider transaction | Feb 7, 2024 | Feb 6, 2024 |
| 4 | Insider transaction | Feb 7, 2024 | Feb 6, 2024 |
| SC 13G | Ownership over 5% (passive) | Feb 7, 2024 | — |
| 4 | Insider transaction | Feb 5, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Feb 5, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Feb 5, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Feb 5, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Feb 5, 2024 | Feb 1, 2024 |
| 3 | Initial insider ownership | Feb 2, 2024 | Feb 1, 2023 |
| 3 | Initial insider ownership | Feb 1, 2024 | Feb 1, 2024 |
| 3 | Initial insider ownership | Feb 1, 2024 | Feb 1, 2024 |
| 3 | Initial insider ownership | Feb 1, 2024 | Feb 1, 2024 |
| 3 | Initial insider ownership | Feb 1, 2024 | Feb 1, 2024 |
| 3 | Initial insider ownership | Feb 1, 2024 | Feb 1, 2024 |
| 3 | Initial insider ownership | Feb 1, 2024 | Feb 1, 2024 |
| 3 | Initial insider ownership | Feb 1, 2024 | Feb 1, 2024 |
| 3 | Initial insider ownership | Feb 1, 2024 | Feb 1, 2024 |
| 3 | Initial insider ownership | Feb 1, 2024 | Feb 1, 2024 |
| 3 | Initial insider ownership | Feb 1, 2024 | Feb 1, 2024 |
Showing 106 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ANRO (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Mountain View, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1999480
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.